Plasma metabonomics as a novel diagnostic approach for major depressive disorder.
about
Research on the Pathological Mechanism and Drug Treatment Mechanism of DepressionRisk assessment and predicting outcomes in patients with depressive symptoms: a review of potential role of peripheral blood based biomarkersProteomics, metabolomics, and protein interactomics in the characterization of the molecular features of major depressive disorder.Social defeat stress causes depression-like behavior with metabolite changes in the prefrontal cortex of rats.The potential biomarker panels for identification of Major Depressive Disorder (MDD) patients with and without early life stress (ELS) by metabonomic analysis.Novel urinary metabolite signature for diagnosing postpartum depressionAltered KYN/TRP, Gln/Glu, and Met/methionine sulfoxide ratios in the blood plasma of medication-free patients with major depressive disorderSex-specific urinary biomarkers for diagnosing bipolar disorder.Altered metabolites in the plasma of autism spectrum disorder: a capillary electrophoresis time-of-flight mass spectroscopy study.Macaques exhibit a naturally-occurring depression similar to humans.Metabolite profiling in posttraumatic stress disorder.The application of HPLC and microprobe NMR spectroscopy in the identification of metabolites in complex biological matrices.1H NMR-based metabolic profiling reveals the effects of fluoxetine on lipid and amino acid metabolism in astrocytes.Combined Metabolomics and Proteomics Analysis of Major Depression in an Animal Model: Perturbed Energy Metabolism in the Chronic Mild Stressed Rat Cerebellum.Hypothalamic Proteomic Analysis Reveals Dysregulation of Glutamate Balance and Energy Metabolism in a Mouse Model of Chronic Mild Stress-Induced Depression.GC-MS-Based Metabonomic Profiling Displayed Differing Effects of Borna Disease Virus Natural Strain Hu-H1 and Laboratory Strain V Infection in Rat Cortical NeuronsBlood diagnostic biomarkers for major depressive disorder using multiplex DNA methylation profiles: discovery and validationMetabolic profiles revealed synergistically antidepressant effects of lilies and Rhizoma Anemarrhenae in a rat model of depression.Specific alterations in plasma proteins during depressed, manic, and euthymic states of bipolar disorder.Identification and validation of urinary metabolite biomarkers for major depressive disorderAbnormal glucose tolerance, white blood cell count, and telomere length in newly diagnosed, antidepressant-naïve patients with depressionChronic unpredictive mild stress leads to altered hepatic metabolic profile and gene expression.Perturbational Profiling of Metabolites in Patient Fibroblasts Implicates α-Aminoadipate as a Potential Biomarker for Bipolar Disorder.Serum proteomic profiling of major depressive disorder.Non-targeted and targeted metabolomics approaches to diagnosing lung cancer and predicting patient prognosis.Gene expression-based biological test for major depressive disorder: an advanced study.The Role of Lipid Biomarkers in Major Depression.Combined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder.(1)H NMR Metabolomic Profiling of Human and Animal Blood Serum Samples.Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry.Proteomic and network analysis of human serum albuminome by integrated use of quick crosslinking and two-step precipitation.Short overview on metabolomic approach and redox changes in psychiatric disorders.Metabolomic analysis based on 1H-nuclear magnetic resonance spectroscopy metabolic profiles in tuberculous, malignant and transudative pleural effusionPlasma lipidomics reveals potential lipid markers of major depressive disorder.Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism.Imbalance in amino acid and purine metabolisms at the hypothalamus in inflammation-associated depression by GC-MS.Hippocampal metabolic differences implicate distinctions between physical and psychological stress in four rat models of depression.Metabolite identification in fecal microbiota transplantation mouse livers and combined proteomics with chronic unpredictive mild stress mouse livers.Biochemical effects of venlafaxine on astrocytes as revealed by 1H NMR-based metabolic profiling.Seeking an objective diagnosis of depression.
P2860
Q26786208-7A51E77A-A693-41F8-BC61-0F6B41B0CD20Q27023402-0A368492-7C88-4097-85B9-FA6A5483B292Q30801268-4E0B773E-7777-4EEB-9566-24C4A92B94D4Q33614561-00DDBF1F-8A1D-47B6-8FCE-7410E2BB72A0Q33679513-8E272402-3EA4-40AA-9494-9876D1E86080Q33704082-48091198-0F01-4EB6-AD99-414A0C1AF68DQ33884852-EE3F3EE9-020D-48D7-8652-CC0C8F9D989FQ34757521-0C049160-7A08-4521-9622-9CDD476F8911Q34994418-4676C763-C37B-4233-B3C5-1A7F6208AC6BQ35188855-EE629074-D9D1-47E9-80BF-C84EBE1381B9Q35200833-08708FB2-4CB4-4B7B-95C6-8D3B296C2C66Q35350423-BF6FF4B3-F3BA-458B-BCC4-B35C35EDB807Q35585693-B00E41F1-348B-47CB-9A81-D6913FE24BC3Q35861541-50F50B6B-B88F-4AB5-ACE9-05FFBE8C7957Q36031835-94BFBB3A-841A-45C0-9406-7D19E71B5765Q36088686-4409F6C0-E122-4C6F-B0EE-EEADE1B7A7F9Q36214173-965B7F27-B293-4497-BB4A-8D3DC14EAD8CQ36232273-F51A0FC8-DE36-412D-8B9B-7EA0222BFBB7Q36351715-AF440ADB-FCDD-4443-BEB2-B7824109C972Q36508139-ADA397E9-8021-4C1E-B988-28B76AE9D2FDQ36653387-2701D9E8-FE1D-46D4-BE12-147B266CDB93Q36719278-B0C9657A-EF41-4871-9769-270BA8C9B83CQ37200180-46D10400-7FC1-43B8-B15E-55DDBE8E118CQ37347574-99DCC250-4736-4742-837D-C4F93B3DCD50Q37665348-3B973B78-EB5D-4FF8-8ABF-9F230F145421Q37669886-5E33EBC2-5606-40F7-8437-7750CD2208CEQ37728018-E456B58E-17C0-4C11-9AFE-39C04FB6CBFBQ37733240-9D60E0C0-CEB3-4C16-B746-25A0E38312CCQ39146383-A7467ED7-9848-4BC2-9DFF-F7B08073DCD0Q40058836-A8D4C3C5-8B63-45DD-920F-453ED5AA118BQ41550303-BD96CB1B-6CC7-47CB-82C9-6F5C7B20EB22Q41791000-0475D5D2-0CCA-432D-B9C4-8903EDDF8A2BQ42347117-E327C3F9-516F-43A2-BFD7-D1A69A9A9BE0Q46511372-D2CB9A7F-9BB2-4AD3-ABDB-711E81594BE1Q46565524-80EC86A4-2ABF-4489-AF1E-379395B9D291Q47436744-71E1E2E8-F451-4E30-9A88-D6582DE7D088Q47562585-A1FC4AE2-0898-4604-91CB-2D8256179960Q47642189-2A739353-E9A7-4CCA-8B48-437C4B2B399BQ48001597-D768E280-8563-4430-A78B-FEAA660376EEQ48048867-B71920F8-9301-4716-BA87-3C75F8665563
P2860
Plasma metabonomics as a novel diagnostic approach for major depressive disorder.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Plasma metabonomics as a novel diagnostic approach for major depressive disorder.
@en
Plasma metabonomics as a novel diagnostic approach for major depressive disorder.
@nl
type
label
Plasma metabonomics as a novel diagnostic approach for major depressive disorder.
@en
Plasma metabonomics as a novel diagnostic approach for major depressive disorder.
@nl
prefLabel
Plasma metabonomics as a novel diagnostic approach for major depressive disorder.
@en
Plasma metabonomics as a novel diagnostic approach for major depressive disorder.
@nl
P2093
P356
P1476
Plasma metabonomics as a novel diagnostic approach for major depressive disorder.
@en
P2093
Hong C Gao
Liang Chen
Liang Fang
Mei L Zhang
Peng Zheng
Song H Fan
P304
P356
10.1021/PR2010082
P577
2012-02-01T00:00:00Z